Status:
COMPLETED
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
Lead Sponsor:
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to explore and compare the perceptions and satisfaction for two different delivery mechanisms for Etanercept (Etanercept Autoinjector and the Etanercept Prefilled Syringe)...
Detailed Description
This study describes patient perceptions related to device attributes, which are of importance in describing overall patient perception. A range of potential device benefits (e.g. ease of use, conveni...
Eligibility Criteria
Inclusion
- Inclusion:
- Diagnosis of RA according to the ACR-Criteria.
- Eligible for treatment with etanercept according to Summary of Product Characteristics (SmPC), and applicable local guidelines.
- Willing and able to self-inject etanercept.
- Exclusion:
- Prior experience of biologics and anti-TNF treatment for their RA including etanercept.
- Sepsis or risk of sepsis.
- Current or recent infections, including chronic or localized.
Exclusion
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
640 Patients enrolled
Trial Details
Trial ID
NCT00459706
Start Date
September 1 2007
End Date
September 1 2009
Last Update
March 28 2013
Active Locations (113)
Enter a location and click search to find clinical trials sorted by distance.
1
Frederiksberg, Denmark, 02000
2
Hjørring, Denmark, 09800
3
Holbæk, Denmark, 04300
4
Silkeborg, Denmark, DK-8600